CA2071946A1 - Toxine utilisee pour la production d'immunotoxines - Google Patents

Toxine utilisee pour la production d'immunotoxines

Info

Publication number
CA2071946A1
CA2071946A1 CA002071946A CA2071946A CA2071946A1 CA 2071946 A1 CA2071946 A1 CA 2071946A1 CA 002071946 A CA002071946 A CA 002071946A CA 2071946 A CA2071946 A CA 2071946A CA 2071946 A1 CA2071946 A1 CA 2071946A1
Authority
CA
Canada
Prior art keywords
lyspe40
cells
molecule
tumor
tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002071946A
Other languages
English (en)
Inventor
Ira H. Pastan
David Fitzgerald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Department of Commerce
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2071946A1 publication Critical patent/CA2071946A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002071946A 1989-12-21 1990-12-21 Toxine utilisee pour la production d'immunotoxines Abandoned CA2071946A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45416289A 1989-12-21 1989-12-21
US454,162 1989-12-21

Publications (1)

Publication Number Publication Date
CA2071946A1 true CA2071946A1 (fr) 1991-06-22

Family

ID=23803558

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002071946A Abandoned CA2071946A1 (fr) 1989-12-21 1990-12-21 Toxine utilisee pour la production d'immunotoxines

Country Status (5)

Country Link
EP (1) EP0506854A4 (fr)
JP (1) JPH04506976A (fr)
AU (1) AU636453B2 (fr)
CA (1) CA2071946A1 (fr)
WO (1) WO1991009965A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672683A (en) * 1989-09-07 1997-09-30 Alkermes, Inc. Transferrin neuropharmaceutical agent fusion protein
US6329508B1 (en) 1989-09-07 2001-12-11 Alkermes, Inc. Transferrin receptor reactive chimeric antibodies
US5977307A (en) * 1989-09-07 1999-11-02 Alkermes, Inc. Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
US5527527A (en) * 1989-09-07 1996-06-18 Alkermes, Inc. Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
US5571894A (en) * 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
US5939531A (en) * 1991-07-15 1999-08-17 Novartis Corp. Recombinant antibodies specific for a growth factor receptor
JPH07509444A (ja) * 1991-11-26 1995-10-19 アルカーメス・インコーポレーテツド トランスフェリンセレプター特異的抗体−神経薬又は診断薬複合体の製造法
US6066718A (en) * 1992-09-25 2000-05-23 Novartis Corporation Reshaped monoclonal antibodies against an immunoglobulin isotype
US6015555A (en) * 1995-05-19 2000-01-18 Alkermes, Inc. Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates
US8932586B2 (en) 2011-09-06 2015-01-13 Intrexon Corporation Modified forms of Pseudomonas exotoxin A
WO2016146833A1 (fr) 2015-03-19 2016-09-22 F. Hoffmann-La Roche Ag Biomarqueurs de résistance à la nad(+)-diphtamide adp-ribosyltransférase
EP3184547A1 (fr) 2015-10-29 2017-06-28 F. Hoffmann-La Roche AG Anticorps anti-tpbg et procédés d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545985A (en) * 1984-01-26 1985-10-08 The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services Pseudomonas exotoxin conjugate immunotoxins
US4892827A (en) * 1986-09-24 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects

Also Published As

Publication number Publication date
EP0506854A1 (fr) 1992-10-07
WO1991009965A1 (fr) 1991-07-11
JPH04506976A (ja) 1992-12-03
AU7172391A (en) 1991-07-24
EP0506854A4 (en) 1992-11-19
AU636453B2 (en) 1993-04-29

Similar Documents

Publication Publication Date Title
US5863745A (en) Recombinant antibody-toxin fusion protein
US5696237A (en) Recombinant antibody-toxin fusion protein
Kondo et al. Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain.
US5608039A (en) Single chain B3 antibody fusion proteins and their uses
US6099842A (en) Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin
Jinno et al. Domain II mutants of Pseudomonas exotoxin deficient in translocation
US5889157A (en) Humanized B3 antibody fragments, fusion proteins, and uses thereof
Batra et al. Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin.
US5854044A (en) Recombinant pseudomonas exotoxin with increased activity
CA2053911C (fr) Proteines recombinantes de fusion anticorps-toxine
US5690928A (en) Method of treating bladder cancer cells
JPH08283293A (ja) 低−動物毒性と高殺細胞活性の改良シュードモナス外毒素
WO1994004689A1 (fr) Toxine recombinee a demi-vie prolongee
JP3512795B2 (ja) 組換免疫毒素
AU636453B2 (en) An improved toxin for construction of immunotoxins
Debinski et al. An immunotoxin with increased activity and homogeneity produced by reducing the number of lysine residues in recombinant Pseudomonas exotoxin
Choe et al. B3 (Fab)-PE38M: a recombinant immunotoxin in which a mutant form of Pseudomonas exotoxin is fused to the Fab fragment of monoclonal antibody B3
Debinski et al. Recombinant F (ab') C242-Pseudomonas exotoxin, but not the whole antibody-based immunotoxin, causes regression of a human colorectal tumor xenograft.
IE84490B1 (en) Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects
NZ238583A (en) Targetted cytotoxic anticancer conjugates and

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead